22 February 2023 Regulatory
Scandion Oncology – Q4 & year-end report 2022
Download
Presentation
Webcast
Workbook
19 January 2023 Regulatory
Scandion Oncology A/S: Scandion Oncology receives favorable opinion from the European Patent Office on Composition of Matter Patent-application for lead compound SCO-101
Download
Presentation
Webcast
Workbook
1 December 2022 Regulatory
Scandion Oncology appoints Francois Martelet, M.D., as new Chief Executive Officer
Download
Presentation
Webcast
Workbook
16 November 2022 Regulatory
Scandion Oncology – Interim Report Q3 2022
Download
Presentation
Webcast
Workbook
28 October 2022 Regulatory
Scandion Oncology Announces Results of Extraordinary General Meeting
Download
Presentation
Webcast
Workbook
13 October 2022 Regulatory
Scandion Oncology – Notice convening an Extraordinary General Meeting
Download
Presentation
Webcast
Workbook
30 September 2022 Regulatory
Scandion Oncology announce topline results from part 2 of the CORIST phase II trial
Download
Presentation
Webcast
Workbook
31 August 2022 Regulatory
Bo Rode Hansen is leaving the position as President and CEO of Scandion Oncology
Download
Presentation
Webcast
Workbook
30 August 2022 Regulatory
Scandion Oncology announce change to its Executive Management
Download
Presentation
Webcast
Workbook
25 August 2022 Regulatory
Scandion Oncology – Interim Report Q2 2022
Download
Presentation
Webcast
Workbook
17 August 2022 Regulatory
Scandion Oncology extends PANTAX trial due to better-than-expected tolerability of SCO-101
Download
Presentation
Webcast
Workbook
1 July 2022 Regulatory
Scandion Oncology announces preliminary outcome of its rights issue
Download
Presentation
Webcast
Workbook
1 June 2022 Regulatory
Scandion Oncology resolves on a Rights Issue of approximately SEK 93.7 million
Download
Presentation
Webcast
Workbook
19 May 2022 Regulatory
Scandion Oncology – Interim Report Q1 2022
Download
Presentation
Webcast
Workbook
27 April 2022 Regulatory
Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors
Download
Presentation
Webcast
Workbook
12 April 2022 Regulatory
Scandion Oncology – Notice convening of Annual General Meeting
Download
Presentation
Webcast
Workbook
24 March 2022 Regulatory
Scandion Oncology – Annual Report 2021
Download
Presentation
Webcast
Workbook
17 February 2022 Regulatory
Scandion Oncology announces its results for the fourth quarter and year-end 2021
Download
Presentation
Webcast
Workbook
1 December 2021 Regulatory
Scandion Oncology announce minutes of Extraordinary General Meeting
Download
Presentation
Webcast
Workbook
18 November 2021 Regulatory
Scandion Oncology A/S announces its results for the third quarter of 2021
Download
Presentation
Webcast
Workbook
17 November 2021 Regulatory
Scandion Oncology announce notice convening an Extraordinary General Meeting
Download
Presentation
Webcast
Workbook
12 November 2021 Regulatory
Scandion Oncology announce cancellation of extraordinary general meeting
Download
Presentation
Webcast
Workbook
2 November 2021 Regulatory
Scandion Oncology A/S: Notice convening an Extraordinary General Meeting
Download
Presentation
Webcast
Workbook
4 October 2021 Regulatory
Scandion Oncology A/S: Cancellation of extraordinary general meeting
Download
Presentation
Webcast
Workbook
21 September 2021 Regulatory
Scandion Oncology A/S: Notice convening an Extraordinary General Meeting
Download
Presentation
Webcast
Workbook
8 September 2021 Regulatory
Scandion Oncology provides a clear path to market for SCO-101 at today’s Capital Markets Day
Download
Presentation
Webcast
Workbook
7 September 2021 Regulatory
Scandion Oncology strengthens its Clinical Advisory Board with three new members
Download
Presentation
Webcast
Workbook
6 September 2021 Regulatory
Scandion Oncology receives approval for initiating the CORIST part 2 trial
Download
Presentation
Webcast
Workbook
2 September 2021 Regulatory
Positive Results from the Scandion Oncology A/S and Alligator Bioscience AB Collaboration Further Supports Efficacy of SCO-101 in Combination Therapy
Download
Presentation
Webcast
Workbook
25 August 2021 Regulatory
First US patent granted to Scandion Oncology on combination treatment with its candidate drug SCO-101
Download
Presentation
Webcast
Workbook
19 August 2021 Regulatory
Scandion Oncology A/S announces its results for the first half year of 2021
Download
Presentation
Webcast
Workbook
24 June 2021 Regulatory
Scandion Oncology reports positive interim results from the CORIST Phase II study
Download
Presentation
Webcast
Workbook
26 May 2021 Regulatory
Scandion Oncology A/S: Minutes of the Annual General Meeting 2021
Download
Presentation
Webcast
Workbook
20 May 2021 Regulatory
Q1 2021 Report: Scandion Oncology is evolving
Download
Presentation
Webcast
Workbook
10 May 2021 Regulatory
Scandion Oncology A/S: Notice convening the Annual General Meeting 2021
Download
Presentation
Webcast
Workbook
29 April 2021 Regulatory
Annual Report 2020: Scandion Oncology is setting the pace for the future
Download
Presentation
Webcast
Workbook
18 February 2021 Regulatory
Year-end Report 2020: Scandion Oncology is poised for the future
Download
Presentation
Webcast
Workbook
28 January 2021 Regulatory
Scandion Oncology adjusts the PANTAX pancreatic cancer study
Download
Presentation
Webcast
Workbook
23 January 2021 Regulatory
Scandion Oncology has finalized the first 12 patients in the CORIST study
Download
Presentation
Webcast
Workbook
15 December 2020 Regulatory
SCANDION ONCOLOGY ANNOUNCES OUTCOME IN THE RIGHTS ISSUE
Download
Presentation
Webcast
Workbook
19 November 2020 Regulatory
Interim Report 1 January 2020 – 30 September 2020
Download
Presentation
Webcast
Workbook
16 November 2020 Regulatory
The Board of Directors of Scandion Oncology has resolved on a fully guaranteed rights issue of approximately SEK 236 million
Download
Presentation
Webcast
Workbook
13 November 2020 Regulatory
Correction: Scandion Oncology – Minutes of extraordinary general meeting
Download
Presentation
Webcast
Workbook
13 November 2020 Regulatory
Scandion Oncology – Minutes of extraordinary general meeting
Download
Presentation
Webcast
Workbook
28 October 2020 Regulatory
Scandion Oncology: Notice to convene Extraordinary General Meeting in Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
28 October 2020 Regulatory
Scandion Oncology A/S initiates its second clinical study with SCO-101
Download
Presentation
Webcast
Workbook
7 October 2020 Regulatory
Scandion Oncology announces modified timelines for clinical studies
Download
Presentation
Webcast
Workbook
6 October 2020 Regulatory
Scandion Oncology receives approximately MSEK 12.3 through successful warrant exercise
Download
Presentation
Webcast
Workbook
3 October 2020 Regulatory
Scandion Oncology announces that it has been selected for the final round of MATWIN presentations
Download
Presentation
Webcast
Workbook
2 October 2020 Regulatory
Communique from the Extraordinary General Meeting of Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
28 September 2020 Regulatory
Scandion Oncology receives final approval from the Danish Medicines Agency and Ethical Committee for start of a clinical trial in patients with pancreatic cancer
Download
Presentation
Webcast
Workbook
16 September 2020 Regulatory
Notice to Extraordinary General Meeting in Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
16 September 2020 Regulatory
Scandion Oncology strengthens executive leadership appointing Bo Rode Hansen as CEO and Nils Brünner as new CSO
Download
Presentation
Webcast
Workbook
20 August 2020 Regulatory
Scandion Oncology announces results from the next evaluable chemo-resistant colorectal cancer patient treated with SCO-101 and chemotherapy
Download
Presentation
Webcast
Workbook
20 August 2020 Regulatory
Half-Year Report 1 January 2020 – 30 June 2020
Download
Presentation
Webcast
Workbook
1 August 2020 Regulatory
Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 10% of the total share amount
Download
Presentation
Webcast
Workbook
31 July 2020 Regulatory
Scandion Oncology drug SCO-101 potentiates the effect of chemotherapy in the first cohort of patients with chemo-resistant metastatic colorectal cancer
Download
Presentation
Webcast
Workbook
11 July 2020 Regulatory
Scandion Oncology announces that the results of the 4 SCO-101 clinical phase I trials have been published in the journal “Basic & Clinical Pharmacology & Toxocology”.
Download
Presentation
Webcast
Workbook
3 July 2020 Regulatory
Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion Oncology
Download
Presentation
Webcast
Workbook
30 June 2020 Regulatory
Scandion Oncology co-founders extend lock-up period
Download
Presentation
Webcast
Workbook
22 June 2020 Regulatory
Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 15% of the total share amount
Download
Presentation
Webcast
Workbook
16 June 2020 Regulatory
Scandion Oncology has received a Eurostars grant of 800,000 EUR, shared with Erasmus Medical Centre, Rotterdam and 2cureX AB, for evaluating SCO-101 against antiestrogen resistance in breast cancer
Download
Presentation
Webcast
Workbook
9 June 2020 Regulatory
Scandion Oncology announces that the Clinical Trial Application for a pancreatic cancer study with chemotherapy and SCO-101 has been submitted to the Danish Medicines Agency and the Ethical Committee.
Download
Presentation
Webcast
Workbook
4 June 2020 Regulatory
Alligator Bioscience and Scandion Oncology sign preclinical agreement to explore combination therapies for chemotherapy and immuno-oncology
Download
Presentation
Webcast
Workbook
27 May 2020 Regulatory
Scandion Oncology announces that the first patient has received treatment with SCO-101 in combination with FOLFIRI.
Download
Presentation
Webcast
Workbook
21 May 2020 Regulatory
Interim report 1 January – 31 March 2020
Download
Presentation
Webcast
Workbook
15 May 2020 Regulatory
Scandion Oncology’s drug SOM-001 demonstrates antibiotic activity in a mouse model infected with MRSA bacteria
Download
Presentation
Webcast
Workbook
11 May 2020 Regulatory
Notice to Annual General Meeting in Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
30 April 2020 Regulatory
Scandion Oncology A/S Annual Report 2019 published
Download
Presentation
Webcast
Workbook
25 March 2020 Regulatory
SCO-101 works in synergy with the chemotherapy drug docetaxel in drug resistant cancer cells
Download
Presentation
Webcast
Workbook
23 March 2020 Regulatory
Clinical development plans for SCO-101
Download
Presentation
Webcast
Workbook
20 March 2020 Regulatory
Short delay of the antibiotic resistance data
Download
Presentation
Webcast
Workbook
9 March 2020 Regulatory
Short delay in the clinical phase II study
Download
Presentation
Webcast
Workbook
20 February 2020 Regulatory
Year-end Report 1 January – 31 December 2019
Download
Presentation
Webcast
Workbook
19 February 2020 Regulatory
Scandion Oncology receives DKK 5 million in soft money from Innovation Fund Denmark
Download
Presentation
Webcast
Workbook
3 February 2020 Regulatory
Correction of dates for public information on Estimated Primary Completion and Primary Study Completion for a Clinical Phase II study
Download
Presentation
Webcast
Workbook
23 December 2019 Regulatory
Scandion Oncology obtains approval from the Ethics Committee on Clinical Application for SCO-101 in patients with drug-resistant metastatic colorectal cancer
Download
Presentation
Webcast
Workbook
16 December 2019 Regulatory
Anti-bacterial treatment: Novel analogues with more than tenfold higher potency identified and technical issues with the in vivo experiments
Download
Presentation
Webcast
Workbook
29 November 2019 Regulatory
Chairman and Vice-Chairman of the Board in Scandion Oncology A/S buy Company shares
Download
Presentation
Webcast
Workbook
29 November 2019 Regulatory
Scandion Oncology receives final approval from the Danish Medicines Agency for start of clinical Phase II trial in patients with drug resistant metastatic colorectal cancer
Download
Presentation
Webcast
Workbook
21 November 2019 Regulatory
Interim Report 1 January 2019 – 30 September 2019
Download
Presentation
Webcast
Workbook
14 October 2019 Regulatory
Scandion Oncology A/S receives EU-patent for SCO-101
Download
Presentation
Webcast
Workbook
1 October 2019 Regulatory
Scandion Oncology applies for start of clinical Phase II trial in patients with metastatic colorectal cancer
Download
Presentation
Webcast
Workbook
1 October 2019 Regulatory
In vivo animal data report on antibiotic resistance extended until mid-Q4 2019
Download
Presentation
Webcast
Workbook
1 October 2019 Regulatory
Peter Høngaard new Chairman of the Board in Scandion Oncology
Download
Presentation
Webcast
Workbook
22 August 2019 Regulatory
Half-Year Report 1 January 2019 – 30 June 2019
Download
Presentation
Webcast
Workbook
12 July 2019 Regulatory
Significantly oversubscribed rights issue in Scandion Oncology
Download
Presentation
Webcast
Workbook
17 June 2019 Regulatory
Scandion Oncology A/S publishes prospectus in connection with rights issue
Download
Presentation
Webcast
Workbook
11 June 2019 Regulatory
Communique from the Extraordinary General Meeting in Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
31 May 2019 Regulatory
Communique from the Annual General Meeting of Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
27 May 2019 Regulatory
Notice of Extraordinary General Meeting in Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
27 May 2019 Regulatory
The board of Scandion Oncology proposes a rights issue to increase the commercial potential for its drug candidates and to expand its drug pipeline
Download
Presentation
Webcast
Workbook
27 May 2019 Regulatory
Interim report 1 January – 31 March 2019
Download
Presentation
Webcast
Workbook
21 May 2019 Regulatory
SCANDION ONCOLOGY A/S obtains “Intention to Grant” notice for SCO-101 from the European Patent Office (EPO)
Download
Presentation
Webcast
Workbook
14 May 2019 Regulatory
Notice to Annual General Meeting in Scandion Oncology A/S
Download
Presentation
Webcast
Workbook
3 May 2019 Regulatory
Scandion Oncology A/S Annual Report 2018 published
Download
Presentation
Webcast
Workbook
16 April 2019 Regulatory
Scandion Oncology signs collaboration agreement with University of Copenhagen regarding co-development of a class of drug candidates that reverts anti-cancer drug resistance
Download
Presentation
Webcast
Workbook
8 April 2019 Regulatory
Scandion Oncology obtains EU Funding for SCO-101 in drug resistant breast cancer patients
Download
Presentation
Webcast
Workbook
26 March 2019 Regulatory
Scandion Oncology A/S reports successful meeting with Danish Medicines Agency regarding clinical development of SCO-101
Download
Presentation
Webcast
Workbook